| Literature DB >> 1400072 |
Abstract
An overview of the steps taken to ensure the safety of blood components and derivatives is provided. A brief discussion of hereditary bleeding disorders (hemophilia A, B, and von Willebrand's disease) is included, and the safety of derivatives available for their treatment is discussed, as well as the method of production and the level of safety of derivatives such as factor VIII and factor IX concentrates.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1400072
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN： 0889-8588 Impact factor: 3.722